申请人:Novapharme
公开号:US05464860A1
公开(公告)日:1995-11-07
The invention relates to a compound useful for treating epilepsy selected from the compounds of the general formula: ##STR1## in which R.sub.1 is C.sub.1 -C.sub.4 alkyl, R.sub.2 is C.sub.1 -C.sub.4 alkyl, R.sub.3 is selected from hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and C.sub.1 -C.sub.4 hydroxyalkyl, and R.sub.4 is selected from hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.7 alkanoyl and C.sub.1 -C.sub.4 hydroxyalkyl.
本发明涉及用于治疗癫痫的化合物,选自具有以下通式的化合物:##STR1## 其中,R.sub.1 是C.sub.1 -C.sub.4烷基,R.sub.2 是C.sub.1 -C.sub.4烷基,R.sub.3 选自氢、C.sub.1 -C.sub.4烷基、C.sub.1 -C.sub.4烷氧基和C.sub.1 -C.sub.4羟基烷基,R.sub.4 选自氢、C.sub.1 -C.sub.4烷基、C.sub.2 -C.sub.7烷酰基和C.sub.1 -C.sub.4羟基烷基。